Search research articles
Contact Us
Filters
Showing results (371-380 of 472) with videos related to
Page
of 48
Sort By:
Molecular Therapy. Nucleic Acids
|
November 24, 2025
MicroRNA-21 is a potential therapeutic agent targeting <i>Tgfbi</i> and mitigating high-fat-diet-induced liver disease and cancer
Urmila Jagtap, Anan Quan, Yuho Ono, et al.
Cell
|
March 16, 2005
RAS is regulated by the let-7 microRNA family
Steven M Johnson, Helge Grosshans, Jaclyn Shingara, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 24, 2011
Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in mice
Phong Trang, Jason F Wiggins, Christopher L Daige, et al.
RNA (New York, N.Y.)
|
December 13, 2018
Human nuclear RNAi-defective 2 (NRDE2) is an essential RNA splicing factor
Alan L Jiao, Roberto Perales, Neil T Umbreit, et al.
Journal of Biotechnology
|
April 29, 2008
Expression of a modified Mannheimia haemolytica GS60 outer membrane lipoprotein in transgenic alfalfa for the development of an edible vaccine against bovine pneumonic pasteurellosis
Raymond W H Lee, Mette Cornelisse, Asma Ziauddin, et al.
Cancer Gene Therapy
|
August 24, 2022
Correction to: MicroRNA-21 guide and passenger strand regulation of adenylosuccinate lyase-mediated purine metabolism promotes transition to an EGFR-TKI-tolerant persister state
Wen Cai Zhang, Nicholas Skiados, Fareesa Aftab, et al.
Pharmacology
|
February 3, 2025
Pharmacological Characterization of GB1908, a Selective Galectin-1 Carbohydrate Binding Domain Inhibitor for the Treatment of Cancer
Kimberly D Herman, Ian Holyer, Duncan C Humphries, et al.
Frontiers in Immunology
|
September 13, 2023
Resistance to anti-PD-1/anti-PD-L1: galectin-3 inhibition with GB1211 reverses galectin-3-induced blockade of pembrolizumab and atezolizumab binding to PD-1/PD-L1
Joseph Mabbitt, Ian D Holyer, James A Roper, et al.
Pathogens (Basel, Switzerland)
|
March 26, 2022
Trash to Treasure: How Insect Protein and Waste Containers Can Improve the Environmental Footprint of Mosquito Egg Releases
Megan J Allman, Aidan J Slack, Nigel P Abello, et al.
Bioorganic & Medicinal Chemistry
|
November 4, 2018
Triazole-linked transition state analogs as selective inhibitors against V. cholerae sialidase
Teri J Slack, Wanqing Li, Dashuang Shi, et al.
Page
of 48
Search research articles
Search
Showing results (371-380 of 472) with videos related to
Sort By:
Page
of 48
Molecular Therapy. Nucleic Acids
|
November 24, 2025
MicroRNA-21 is a potential therapeutic agent targeting <i>Tgfbi</i> and mitigating high-fat-diet-induced liver disease and cancer
Urmila Jagtap, Anan Quan, Yuho Ono, et al.
Cell
|
March 16, 2005
RAS is regulated by the let-7 microRNA family
Steven M Johnson, Helge Grosshans, Jaclyn Shingara, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 24, 2011
Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in mice
Phong Trang, Jason F Wiggins, Christopher L Daige, et al.
RNA (New York, N.Y.)
|
December 13, 2018
Human nuclear RNAi-defective 2 (NRDE2) is an essential RNA splicing factor
Alan L Jiao, Roberto Perales, Neil T Umbreit, et al.
Journal of Biotechnology
|
April 29, 2008
Expression of a modified Mannheimia haemolytica GS60 outer membrane lipoprotein in transgenic alfalfa for the development of an edible vaccine against bovine pneumonic pasteurellosis
Raymond W H Lee, Mette Cornelisse, Asma Ziauddin, et al.
Cancer Gene Therapy
|
August 24, 2022
Correction to: MicroRNA-21 guide and passenger strand regulation of adenylosuccinate lyase-mediated purine metabolism promotes transition to an EGFR-TKI-tolerant persister state
Wen Cai Zhang, Nicholas Skiados, Fareesa Aftab, et al.
Pharmacology
|
February 3, 2025
Pharmacological Characterization of GB1908, a Selective Galectin-1 Carbohydrate Binding Domain Inhibitor for the Treatment of Cancer
Kimberly D Herman, Ian Holyer, Duncan C Humphries, et al.
Frontiers in Immunology
|
September 13, 2023
Resistance to anti-PD-1/anti-PD-L1: galectin-3 inhibition with GB1211 reverses galectin-3-induced blockade of pembrolizumab and atezolizumab binding to PD-1/PD-L1
Joseph Mabbitt, Ian D Holyer, James A Roper, et al.
Pathogens (Basel, Switzerland)
|
March 26, 2022
Trash to Treasure: How Insect Protein and Waste Containers Can Improve the Environmental Footprint of Mosquito Egg Releases
Megan J Allman, Aidan J Slack, Nigel P Abello, et al.
Bioorganic & Medicinal Chemistry
|
November 4, 2018
Triazole-linked transition state analogs as selective inhibitors against V. cholerae sialidase
Teri J Slack, Wanqing Li, Dashuang Shi, et al.
Page
of 48